The objectives of this comprehensive review were to provide an overview of the roles of MYC in precancerous and cancerous cells and to discuss the design and properties of MYC inhibitors, especially modulators from medicinal herbs, that have been brought to market or are undergoing pre-clinical cancer therapy studies. The gene discussed is MYC; the disease is cancer.